These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3069616)
1. [Preliminary results of studies of the effect of immunostimulation combined with chemotherapy in patients with ovarian cancer]. Pawlicki M; Majsak T Ginekol Pol; 1988 Jun; 59(6):358-62. PubMed ID: 3069616 [No Abstract] [Full Text] [Related]
2. Chemotherapy and corynebacterium parvum for induction and maintenance of remission in acute myelogenous leukaemia--a controlled study. Shetty PA; Pai VR; Jani PH; Antia PK; Shahane AD Indian J Cancer; 1983; 20(2):119-23. PubMed ID: 6580265 [No Abstract] [Full Text] [Related]
3. Treatment of advanced ovarian malignancy with chemoimmunotherapy using autologous tumor and Corynebacterium parvum. Gusdon JP; Homesley HD; Jobson VW; Muss HB Obstet Gynecol; 1983 Dec; 62(6):728-35. PubMed ID: 6633998 [TBL] [Abstract][Full Text] [Related]
4. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia. Lancet; 1987 Aug; 2(8555):353-9. PubMed ID: 2886821 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of 3-drug therapy in patients with advanced ovarian cancer]. Kwaśniewska-Rokicińska C; Kaleta B; Kumor-Głodny T Ginekol Pol; 1989 Feb; 60(2):86-9. PubMed ID: 2680790 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer. Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455 [TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate with "RESCUE" plus cyclophosphamide as initial chemotherapy in ovarian adenocarcinoma. A randomized trial with observations on the influence of C parvum immunotherapy. Barlow JJ; Piver MS; Lele SB Cancer; 1980 Sep; 46(6):1333-8. PubMed ID: 6998553 [TBL] [Abstract][Full Text] [Related]
9. [An evaluation of two postoperative chemotherapy protocols in ovarian common epithelial cancer: a comparison of continuous and intermittent hospitalization]. Sakamoto H; Suzuki H; Hayakawa S; Kiseki Y; Miyakawa Y; Ohkubo Y; Watanabe Y; Takami M; Kashiwazaki K; Tanaka H Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1491-4. PubMed ID: 2584826 [No Abstract] [Full Text] [Related]
10. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer. Vanhaelen CP; Fisher RI Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085 [TBL] [Abstract][Full Text] [Related]
11. The sequential multiple modality treatment of ovarian cancer. Dembo AJ Radiother Oncol; 1985 Apr; 3(3):187-92. PubMed ID: 3923573 [No Abstract] [Full Text] [Related]
12. A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. Conte PF; Bruzzone M; Chiara S; Sertoli MR; Daga MG; Rubagotti A; Conio A; Ruvolo M; Rosso R; Santi L J Clin Oncol; 1986 Jun; 4(6):965-71. PubMed ID: 3519886 [TBL] [Abstract][Full Text] [Related]
13. [Results of the first Austrian multicenter ovarian cancer study: prospective randomized comparison of sequential chemotherapy (adriamycin/cisplatin--vincristine/cyclophosphamide--methotrexate) with 2 standard protocols (adriamycin/cyclophosphamide or adriamycin/cisplatin) in stage III and IV patients]. Salzer H; Gitsch E; Dittrich C; Sevelda P; Karrer K; Schemper M; Stempel-Smekal G; Langer M; Wagner G; Rainer H Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):761-8. PubMed ID: 3908214 [TBL] [Abstract][Full Text] [Related]
14. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma. Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166 [TBL] [Abstract][Full Text] [Related]
17. [Effect of intratumor administration of Propionibacterium granulosum in patients with advanced breast carcinoma on the clinical course of the disease and the behavior of certain indices of immune resistance]. Płuzańska A; Stempczyńska J; Szmigielski S; Jeljaszewicz J Pol Arch Med Wewn; 1985 Jun; 73(6):351-60. PubMed ID: 3880373 [No Abstract] [Full Text] [Related]
18. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience. Cohen CJ; Bruckner HW; Goldberg JD; Holland JF Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114 [No Abstract] [Full Text] [Related]
19. Multimodal approach to the treatment of stage III ovarian carcinoma: preliminary report of a pilot study and critical review. Paule B; Frydman R; Chasseray JM Biomed Pharmacother; 1985; 39(5):241-5. PubMed ID: 4084658 [TBL] [Abstract][Full Text] [Related]
20. Management of recurrent ovarian carcinoma. Ang PT; Kavanagh J Am J Clin Oncol; 1989 Jun; 12(3):269-72. PubMed ID: 2543208 [No Abstract] [Full Text] [Related] [Next] [New Search]